United States · 
Who invested in Grannus Therapeutics?
Grannus Therapeutics's investors include Elevate Ventures.
United States · Funded startup
Who invested in Grannus Therapeutics
Funding summaryUpdated 26 Oct 2026
$800Kraised across 1 round since 2024, from 1 source
- Latest round
- Debt, $800KJan 2024
- Investors
- 1
The rounds
- Jan 2024
Founders and team
From Grannus Therapeutics's own website and the SEC filings it signed: 2 founders, 2 on the team.
John FoglesongCo-Founder & CEONamed on its 2024 Form D
Sanket MishraPh.D., Co-Founder & VP Research
- Daniel L. FlynnPh.D., CSO & Board Member
- Udayan GuhaPh.D., Member Board of Directors
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Grannus Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Grannus Therapeutics
How much has Grannus Therapeutics raised?
Grannus Therapeutics has raised $800K across 1 round since 2024.
When did Grannus Therapeutics last raise?
Grannus Therapeutics's most recent round was a Debt of $800K in Jan 2024.
What was Grannus Therapeutics's biggest round?
Its most recent round, $800K in Jan 2024, is also its largest on record.
Who backed Grannus Therapeutics first?
Grannus Therapeutics's first round on record, in Jan 2024, was backed by Elevate Ventures.
What stage is Grannus Therapeutics at?
Grannus Therapeutics's latest named round is a Debt, in Jan 2024.
Where is Grannus Therapeutics based?
Grannus Therapeutics is based in the United States.
Companies like Grannus Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.